Schematic representation of the experimental protocol over time. حسب Vanessa Wellauer (18408477)

الموضوعات:

Pairwise comparisons of the intervention effects by time point for physiological parameters. حسب Vanessa Wellauer (18408477)

الموضوعات:

CONSORT flowchart of participants. حسب Vanessa Wellauer (18408477)

الموضوعات:

Pairwise comparisons of the intervention effects by time point for recovery parameter. حسب Vanessa Wellauer (18408477)

الموضوعات:

Lipid layer thickness distribution in the inferior half of cornea (nm). حسب Yongwoo Lee (2265172)

الموضوعات:

Flowchart of overall study protocol. حسب Yongwoo Lee (2265172)

الموضوعات:

Changes in symptom scores and signs of dry eye disease and meibomian gland dysfunction after treatment with intensive pulse light and meibomian gland expression (n =  218). حسب Yongwoo Lee (2265172)

الموضوعات:

Change in the vertical distribution of the lipid layer thickness after intensive pulse light treatment (IPL; nm) combined with meibomian gland expression (MGX). حسب Yongwoo Lee (2265172)

الموضوعات:

Patient demographics. حسب Yongwoo Lee (2265172)

الموضوعات:

The catalase enzyme response of <i>A</i>. <i>albopictus</i> larvae decreased (1.5-fold) in response to <i>M</i>. <i>robertsii</i>-derived copper nanoparticles. حسب Perumal Vivekanandhan (4863484)

Mean GHQ scores (2019- September 2021). حسب Mhairi Webster (20454888)

Receiver operating characteristic curve for anti-NIE antibodies for <i>S. stercoralis.</i> حسب Jannet A. Tobon Ramos (20855642)

"…The seroprevalence did not significantly decrease following DA treatment. These results include all individuals sampled, irrespective of whether they took the medications. …"

Between the PCSO-524 group and the placebo group unpaired comparisons of the change between visits of quality of life and respiratory variables scores. حسب Nattapon Riengvirodkij (11268720)

الموضوعات:

A flow diagram outlining the number of dogs in each group during the study (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70). حسب Nattapon Riengvirodkij (11268720)

الموضوعات:

Distribution of quality of life and respiratory variables scores of all 3 visits (visit = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group... حسب Nattapon Riengvirodkij (11268720)

الموضوعات:

The baseline characteristics of classifications and body condition score of the 2 groups (frequencies) at entry (visit 1, day 0). حسب Nattapon Riengvirodkij (11268720)

الموضوعات:

Tricuspid regurgitation pressure gradient of all 17 dogs. حسب Nattapon Riengvirodkij (11268720)

الموضوعات:

Tricuspid regurgitation pressure gradient in the PCSO-524 and placebo groups. حسب Nattapon Riengvirodkij (11268720)

الموضوعات:

Reducing Dscam1 diversity decreases adult lifespan in a cluster-specific manner, also see S6 and S7 Figs. حسب Haiyang Dong (4783608)

FGF18 injections increase TIMP1 and decrease MMP13 and NOGGIN, suggesting healing of degeneration induction of anabolic effect. حسب Flavia Gomes Velasque Gama (21175112)